Millstone Evans Group, LLC United Therapeutics Corp Transaction History
Millstone Evans Group, LLC
- $147 Billion
- Q4 2024
A detailed history of Millstone Evans Group, LLC transactions in United Therapeutics Corp stock. As of the latest transaction made, Millstone Evans Group, LLC holds 190 shares of UTHR stock, worth $65,671. This represents 0.05% of its overall portfolio holdings.
Number of Shares
190Holding current value
$65,671% of portfolio
0.05%Shares
1 transactions
Others Institutions Holding UTHR
# of Institutions
692Shares Held
60.7MCall Options Held
194KPut Options Held
292K-
Wealthfront Advisers LLC18.3MShares$6.33 Billion5.38% of portfolio
-
Black Rock Inc. New York, NY5.47MShares$1.89 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.44MShares$1.54 Billion0.03% of portfolio
-
Wellington Management Group LLP Boston, MA3.17MShares$1.1 Billion0.2% of portfolio
-
Avoro Capital Advisors LLC New York, NY2.86MShares$988 Million15.42% of portfolio
About UNITED THERAPEUTICS Corp
- Ticker UTHR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 45,516,300
- Market Cap $15.7B
- Description
- United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...